Protagenic Therapeutics I...

NASDAQ: PTIX · Real-Time Price · USD
2.92
-0.15 (-4.89%)
At close: Aug 15, 2025, 3:59 PM
2.88
-1.41%
After-hours: Aug 15, 2025, 07:55 PM EDT

Protagenic Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
50.29K 28.22K n/a n/a
Gross Profit
n/a -28.22K n/a n/a
Operating Income
-5.7M -4.53M -3.56M -4.14M
Interest Income
43.47K 264.48K 185.79K 33.21K
Pretax Income
-5.53M -5M -3.56M -4.52M
Net Income
-5.53M -5M -3.56M -4.52M
Selling & General & Admin
1.76M 1.18M 1.97M 3M
Research & Development
3.85M 3.32M 1.59M 1.14M
Other Expenses
97.36K n/a n/a n/a
Operating Expenses
5.7M 4.5M 3.56M 4.14M
Interest Expense
n/a 107.68K 137.46K 496.91K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
5.7M 4.53M 3.56M 4.14M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
4.9M 4.34M 4.32M 3.69M
Shares Outstanding (Diluted)
4.9M 4.34M 4.32M 3.69M
EPS (Basic)
-1.13 -1.15 -0.83 -1.24
EPS (Diluted)
-1.13 -1.15 -0.83 -1.24
EBITDA
-5.47M -4.5M -3.37M -4.14M
EBIT
-5.53M -4.53M -3.42M -4.14M
Depreciation & Amortization
50.29K 28.22K 30.00 286.00